metformin and glp 1 for weight loss Tirzepatide Together Loss: Clinical Guide Metformin for GLP-1 Therapy in

A new real-world study reveals that advanced GLP-1 therapies, including semaglutide and tirzepatide, provide comparable glycemic control while offering superior weight benefits compared to metformin in adolescents newly diagnosed with type 2 diabetes

These real-world observations underscore the direct anti-inflammatory power of GLP-1s, suggesting benefits for inflammation even when weight loss isn't the primary outcome

Wegovy lawsuits allege that manufacturer Novo Nordisk failed to warn consumers of all risks, negligently misrepresented the product and engaged in harmful marketing practices

All experiments were performed in triplicate wells and repeated at least three times

Lancet Gastroenterol Hepatol 2024

Thats just food working